Profile
Bryan Gillis worked as the Vice President-Manufacturing & Supply at Rubius Therapeutics, Inc. from 2018 to 2022.
He then served as the Chief Technology Officer at Finch Therapeutics Group, Inc. in 2022 to 2023.
Mr. Gillis holds an MBA from Boston University and an undergraduate degree from Eastern Nazarene College.
Former positions of Bryan Gillis
| Companies | Position | End |
|---|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Chief Tech/Sci/R&D Officer | 28/02/2023 |
| RUBIUS THERAPEUTICS | Corporate Officer/Principal | 31/01/2022 |
Training of Bryan Gillis
| Eastern Nazarene College | Undergraduate Degree |
| Boston University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Health Services |
| Private companies | 1 |
|---|---|
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
- Stock Market
- Insiders
- Bryan Gillis
